{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:53:24Z","timestamp":1792612404399,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270069 and 82370073"],"award-info":[{"award-number":["82270069 and 82370073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270069 and 82370073"],"award-info":[{"award-number":["82270069 and 82370073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270069 and 82370073"],"award-info":[{"award-number":["82270069 and 82370073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Project of Natural Science Foundation of Tianjin","award":["2023F1-0019"],"award-info":[{"award-number":["2023F1-0019"]}]},{"name":"Key Project of Natural Science Foundation of Tianjin","award":["2023F1-0019"],"award-info":[{"award-number":["2023F1-0019"]}]},{"name":"Key Project of Natural Science Foundation of Tianjin","award":["2023F1-0019"],"award-info":[{"award-number":["2023F1-0019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02153-9","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T21:02:12Z","timestamp":1729630932000},"page":"1760-1774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-\u03b21 Pathway"],"prefix":"10.1007","volume":"48","author":[{"given":"Yuming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"2153_CR1","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.coph.2022.102211","volume":"64","author":"Heather Bukiri","year":"2022","unstructured":"Bukiri, Heather, and Elizabeth R. Volkmann. 2022. Current advances in the treatment of systemic sclerosis [J]. Current Opinion in Pharmacology 64: 102211.","journal-title":"Current Opinion in Pharmacology"},{"issue":"2","key":"2153_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1164\/rccm.202306-1113ST","volume":"209","author":"G Raghu","year":"2024","unstructured":"Raghu, G., S.B. Montesi, R.M. Silver, et al. 2024. Treatment of systemic sclerosis-associated interstitial lung disease: Evidence-based recommendations. An official American thoracic society clinical practice guideline [J]. American Journal of Respiratory and Critical Care Medicine 209 (2): 137\u2013152.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2153_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/acr.21583","volume":"64","author":"R Steele","year":"2012","unstructured":"Steele, R., M. Hudson, E. Lo, et al. 2012. Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis[J]. Arthritis Care Res (Hoboken) 64: 519\u2013524.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"2153_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.2174\/138161210790963760","volume":"16","author":"Keravis Therese","year":"2010","unstructured":"Therese, Keravis, and Lugnier Claire. 2010. Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs[J]. Current Pharmaceutical Design 16 (9): 1114\u20131125.","journal-title":"Current Pharmaceutical Design"},{"issue":"167","key":"2153_CR5","doi-asserted-by":"publisher","first-page":"220206","DOI":"10.1183\/16000617.0206-2022","volume":"32","author":"Martin Kolb","year":"2023","unstructured":"Kolb, Martin, Bruno Crestani, and Toby M. Maher. 2023. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis[J]. European Respiratory Review 32 (167): 220206.","journal-title":"European Respiratory Review"},{"key":"2153_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","volume":"7","author":"VK Raker","year":"2016","unstructured":"Raker, V.K., C. Becker, and K. Steinbrink. 2016. The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases[J]. Frontiers in Immunology 7: 123.","journal-title":"Frontiers in Immunology"},{"key":"2153_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1210\/er.2013-1053","volume":"35","author":"MF Azevedo","year":"2014","unstructured":"Azevedo, M.F., F.R. Faucz, E. Bimpaki, et al. 2014. Clinical and molecular genetics of the phosphodiesterases (PDEs)[J]. Endocrine Reviews 35: 195\u2013233.","journal-title":"Endocrine Reviews"},{"key":"2153_CR8","first-page":"1663","volume":"13","author":"Su Yue","year":"2022","unstructured":"Yue, Su., Ding Jiaxiang, Yang Fan, et al. 2022. The regulatory role of PDE4B in the progression of inflammatory function study[J]. Frontiers in Pharmacology 13: 1663\u20139812.","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"2153_CR9","first-page":"517","volume":"2","author":"WM Brown","year":"2007","unstructured":"Brown, W.M. 2007. Treating COPD with PDE 4 inhibitors[J]. International Journal of Chronic Obstructive Pulmonary Disease 2 (4): 517\u2013533.","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"2153_CR10","doi-asserted-by":"publisher","first-page":"19378","DOI":"10.1038\/s41598-023-46737-1","volume":"13","author":"T Higuchi","year":"2023","unstructured":"Higuchi, T., K. Takagi, A. Tochimoto, et al. 2023. Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model[J]. Science and Reports 13: 19378.","journal-title":"Science and Reports"},{"key":"2153_CR11","doi-asserted-by":"publisher","first-page":"1111393","DOI":"10.3389\/fphar.2023.1111393","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang, X., Z. Xu, S. Hu, et al. 2023. Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis[J]. Frontiers in Pharmacology 14: 1111393.","journal-title":"Frontiers in Pharmacology"},{"key":"2153_CR12","doi-asserted-by":"publisher","first-page":"838449","DOI":"10.3389\/fphar.2022.838449","volume":"13","author":"FE Herrmann","year":"2022","unstructured":"Herrmann, F.E., C. Hesslinger, L. Wollin, et al. 2022. BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis[J]. Frontiers in Pharmacology 13: 838449.","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"2153_CR13","doi-asserted-by":"publisher","first-page":"00240","DOI":"10.1183\/23120541.00240-2022","volume":"8","author":"TM Maher","year":"2022","unstructured":"Maher, T.M., C. Schlecker, D. Luedtke, et al. 2022. Phase I studies of BI 1015550, a preferential phosphodiesterase 4B inhibitor, in healthy males and patients with idiopathic pulmonary fibrosis[J]. ERJ Open Research 8 (4): 00240\u201302022.","journal-title":"ERJ Open Research"},{"key":"2153_CR14","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu, G., M. Remy-Jardin, L. Richeldi, et al. 2022. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline[J]. American Journal of Respiratory and Critical Care Medicine 205: e18\u2013e47.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2153_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1136\/annrheumdis-2016-210189","volume":"76","author":"C Maier","year":"2017","unstructured":"Maier, C., A. Ramming, C. Bergmann, et al. 2017. Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages[J]. Annals of the Rheumatic Diseases 76: 1133\u20131141.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"10","key":"2153_CR16","first-page":"1951","volume":"40","author":"C Bruni","year":"2022","unstructured":"Bruni, C., L. Chung, A.M. Hoffmann-Vold, et al. 2022. High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: A EUSTAR-SCTC survey [J]. Clinical and Experimental Rheumatology 40 (10): 1951\u20131955.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"2153_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","volume":"374","author":"PM Calverley","year":"2009","unstructured":"Calverley, P.M., K.F. Rabe, U.M. Goehring, et al. 2009. Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trials[J]. Lancet 374: 685\u2013694.","journal-title":"Lancet"},{"issue":"8","key":"2153_CR18","doi-asserted-by":"publisher","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","volume":"306","author":"R Lee","year":"2014","unstructured":"Lee, R., C. Reese, M. Bonner, et al. 2014. Bleomycin delivery by osmotic minipump: Similarity to human scleroderma interstitial lung disease[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology 306 (8): L736\u2013L748.","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"key":"2153_CR19","doi-asserted-by":"publisher","first-page":"114103","DOI":"10.1016\/j.bcp.2020.114103","volume":"178","author":"A Lescoat","year":"2020","unstructured":"Lescoat, A., M. Lelong, M. Jeljeli, et al. 2020. Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease[J]. Biochemical Pharmacology 178: 114103.","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"2153_CR20","first-page":"2243","volume":"34","author":"PQ Hu","year":"2007","unstructured":"Hu, P.Q., A.A. Hurwitz, and J.J. Oppenheim. 2007. Immunization with DNA topoisomerase I induces autoimmune responses but not scleroderma-like pathologies in mice[J]. Journal of Rheumatology 34 (11): 2243\u20132252.","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"2153_CR21","first-page":"558","volume":"35","author":"Y Aso","year":"1976","unstructured":"Aso, Y., K. Yoneda, and Y. Kikkawa. 1976. Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice[J]. Laboratory Investigation 35 (6): 558\u2013568.","journal-title":"Laboratory Investigation"},{"issue":"11","key":"2153_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s004030000183","volume":"292","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto, T., M. Kuroda, and K. Nishioka. 2000. Animal model of sclerotic skin. III: histopathological comparison of bleomycin-induced scleroderma in various mice strains[J]. Archives of Dermatological Research 292 (11): 535\u2013541.","journal-title":"Archives of Dermatological Research"},{"issue":"1","key":"2153_CR23","doi-asserted-by":"publisher","first-page":"18513","DOI":"10.1038\/s41598-021-97728-z","volume":"11","author":"F Ravanetti","year":"2021","unstructured":"Ravanetti, F., E. Ferrini, L. Ragionieri, et al. 2021. SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: Effect of Nintedanib[J]. Science and Reports 11 (1): 18513.","journal-title":"Science and Reports"},{"key":"2153_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.retram.2016.06.003","volume":"64","author":"NN Do","year":"2016","unstructured":"Do, N.N., and S.A. Eming. 2016. Skin fibrosis: Models and mechanisms[J]. Current Research in Translational Medicin 64: 185\u2013193.","journal-title":"Current Research in Translational Medicin"},{"issue":"135","key":"2153_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1183\/09059180.00003214","volume":"24","author":"G Bagnato","year":"2015","unstructured":"Bagnato, G., and S. Harari. 2015. Cellular interactions in the pathogenesis of interstitial lung diseases[J]. European Respiratory Review\u202f: An Official Journal of the European Respiratory Society 24 (135): 102\u2013114.","journal-title":"European Respiratory Review : An Official Journal of the European Respiratory Society"},{"issue":"9","key":"2153_CR26","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1183\/09031936.94.07091678","volume":"7","author":"ML Lohmann-Matthes","year":"1994","unstructured":"Lohmann-Matthes, M.L., C. Steinm\u00fcller, and G. Franke-Ullmann. 1994. Pulmonary macrophages [J]. The European Respiratory Journal 7 (9): 1678\u20131689.","journal-title":"The European Respiratory Journal"},{"key":"2153_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-019-2074-9","volume":"21","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z., Y. Wu, B. Wu, et al. 2019. DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models[J]. Arthritis Research & Therapy 21: 1\u201315.","journal-title":"Arthritis Research & Therapy"},{"key":"2153_CR28","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H., J. Zuo, and W. Tang. 2018. Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases[J]. Frontiers in Pharmacology 9: 1048.","journal-title":"Frontiers in Pharmacology"},{"key":"2153_CR29","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41573-019-0033-4","volume":"18","author":"GS Baillie","year":"2019","unstructured":"Baillie, G.S., G.S. Tejeda, and M.P. Kelly. 2019. Therapeutic targeting of 3\u2019,5\u2019-cyclic nucleotide phosphodiesterases: Inhibition and beyond[J]. Nature Reviews Drug Discovery 18: 770\u2013796.","journal-title":"Nature Reviews Drug Discovery"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02153-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02153-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T23:47:32Z","timestamp":1757116052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02153-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2153"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02153-9","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal care and experimental procedures were approved by the Experimental Animal Care and Use Committee of Nankai Animal Resources Center (Approval number 2024-SYDWLL-000001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors give their full consent to publish the present article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}